Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock at $59.62 per share on August 13, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On August 13, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock.
- The sale was executed at a price of $59.62 per share.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 11, 2023.
- Following the transaction, Meredith Cook directly owns 56,988 shares of ANI Pharmaceuticals.
- The filing was submitted on August 14, 2024.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to an executive's stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Executive stock sales are a common occurrence and are often related to personal financial planning rather than a reflection of the company's prospects. The use of a 10b5-1 trading plan suggests the sale was pre-planned.
Key Dates
| Date | Description |
|---|---|
| 08/11/2023 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| 08/13/2024 | Date of the transaction (stock sale) |
| 08/14/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.